| pubmed-article:2311650 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0021494 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0879438 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0887936 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
| pubmed-article:2311650 | lifeskim:mentions | umls-concept:C1881865 | lld:lifeskim |
| pubmed-article:2311650 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2311650 | pubmed:dateCreated | 1990-4-23 | lld:pubmed |
| pubmed-article:2311650 | pubmed:abstractText | Previously, we have shown that the intravenous (i.v.) injection of allogeneic lymphocytes across an H-2 class I-mutant disparity leads to specific skin allograft tolerance caused by irradiation-sensitive donor T cells, which function as veto cells. In the present study, we show that the i.v. injection of H-2 class II-incompatible spleen cells also results in specific skin allograft tolerance. However, tolerance induction depends on the presence of irradiation-resistant non-T cells in the donor cell inoculum. Thus, different mechanisms operate in tolerance induction across an H-2 class I vs. H-2 class II mismatch. I.v. injection of allogeneic spleen cells across an H-2 class I plus class II disparity does not result in skin allograft tolerance. Finally, our data show that transfusion-induced suppression of the delayed-type hypersensitivity response against alloantigens does not correlate with skin allograft tolerance induced by i.v. injected allogeneic lymphocytes. In conclusion, the type of H-2 mismatch between transfusion donor and recipient not only determines the occurrence of allograft tolerance but also the mechanism leading to tolerization. | lld:pubmed |
| pubmed-article:2311650 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2311650 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2311650 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2311650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2311650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2311650 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2311650 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:2311650 | pubmed:issn | 0014-2980 | lld:pubmed |
| pubmed-article:2311650 | pubmed:author | pubmed-author:MeliefC JCJ | lld:pubmed |
| pubmed-article:2311650 | pubmed:author | pubmed-author:KastW MWM | lld:pubmed |
| pubmed-article:2311650 | pubmed:author | pubmed-author:van TwuyverEE | lld:pubmed |
| pubmed-article:2311650 | pubmed:author | pubmed-author:MooijaartR... | lld:pubmed |
| pubmed-article:2311650 | pubmed:author | pubmed-author:De WaalL PLP | lld:pubmed |
| pubmed-article:2311650 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2311650 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:2311650 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2311650 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2311650 | pubmed:pagination | 441-4 | lld:pubmed |
| pubmed-article:2311650 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:meshHeading | pubmed-meshheading:2311650-... | lld:pubmed |
| pubmed-article:2311650 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2311650 | pubmed:articleTitle | Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. | lld:pubmed |
| pubmed-article:2311650 | pubmed:affiliation | Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam. | lld:pubmed |
| pubmed-article:2311650 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2311650 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2311650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2311650 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2311650 | lld:pubmed |
